HLB Panagene Co., Ltd. (KOSDAQ:046210)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,174.00
+26.00 (2.26%)
At close: Sep 11, 2026

HLB Panagene Revenue

HLB Panagene had revenue of 3.71B KRW in the quarter ending June 30, 2026, with 1.87% growth. This brings the company's revenue in the last twelve months to 14.71B, up 1.40% year-over-year. In the year 2025, HLB Panagene had annual revenue of 15.05B with 14.04% growth.

Revenue (ttm)
14.71B
Revenue Growth
+1.40%
P/S Ratio
3.63
Revenue / Employee
179.37M
Employees
82
Market Cap
53.45B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202515.05B1.85B14.04%
Dec 31, 202413.20B944.89M7.71%
Dec 31, 202312.25B-16.39B-57.22%
Dec 31, 201228.64B-12.81B-30.91%
Dec 31, 201141.45B7.41B21.77%
Dec 31, 2010 Pro Pro Pro
Dec 31, 2009 Pro Pro Pro
Dec 31, 2008 Pro Pro Pro
Dec 31, 2007 Pro Pro Pro
Dec 31, 2006 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
GC Medical Science102.16B
Seoulin Bioscience83.17B
Cytogen27.38B
Dx & Vx26.22B
Protia17.75B
3billion11.71B
GENINUS11.28B
Median Diagnostics7.86B
Revenue Rankings